As adenoviral overexpression [13, 14] and intranasal delivery of recombinant IL-33 [16] has been reported to increase lymphocyte and neutrophil numbers, our results, in combination with previously published data, suggest that IL-33 signalling promotes inflammation in the early injury phase of the BLM model of lung fibrosis. The gene discussed is IL33; the disease is pulmonary fibrosis.